Home/Filings/4/0000899243-19-013720
4//SEC Filing

Zeeman Gregory T 4

Accession 0000899243-19-013720

CIK 0001529864other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 3:16 PM ET

Size

10.1 KB

Accession

0000899243-19-013720

Insider Transaction Report

Form 4
Period: 2019-02-12
Zeeman Gregory T
EVP- Chief Operating Officer
Transactions
  • Award

    Common stock, par value $0.00001

    2019-02-12+29,873209,594 total
  • Award

    Stock Option (right to buy) with limited SAR

    2019-02-12+65,051484,733 total
    Exercise: $21.34Exp: 2026-02-12Common stock, par value $0.00001 per share (65,051 underlying)
Footnotes (7)
  • [F1]This transaction reflects a grant of Restricted Stock Units ("RSUs") that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate thereof through the applicable vesting date: February 12, 2020, February 12, 2021, February 12, 2022 and February 12, 2023.
  • [F2]This transaction reflects a grant of time-based Restricted Stock Units ("RSUs") previously granted to the Reporting Person as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate thereof. These RSUs were omitted from the Form 4s filed by the reporting person after February 12, 2019.
  • [F3]Includes timed-based restricted stock units previously granted to the Reporting Person.
  • [F4]The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
  • [F5]The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
  • [F6]The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 12, 2020, February 12, 2021 and February 12, 2022.
  • [F7]This transaction reflects a grant of stock options ("SOs") previously granted to the Reporting Person as long as grantee serves as an employee of Enova International, Inc. ("Issuer") or an affiliate thereof. These RSUs were omitted from the Form 4s filed by the reporting person after February 12, 2019.

Issuer

Enova International, Inc.

CIK 0001529864

Entity typeother

Related Parties

1
  • filerCIK 0001544218

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 3:16 PM ET
Size
10.1 KB